Related Experiment Video
Updated: Apr 17, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Using Quality Improvement to Reduce Loss to Follow-Up in Pediatric Patients With Type 1 Diabetes
Meenal Gupta1, Lori E Rutman1,2, Kristen Carlin3
1Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington.
Background:
Quarterly diabetes clinic visits are recommended for pediatric patients with type 1 diabetes (T1D). Lower rates of clinic visit attendance are associated with higher hemoglobin A1c (HbA1c) levels. We aimed to reduce the proportion of patients younger than 18 years with T1D who were lost to follow-up (LTFU) from a baseline of 38% to 20% in 18 months.
Methods:
A multidisciplinary team consisting of endocrinologists, clinic leadership, and program managers reviewed the existing scheduling process and created a driver diagram for improvement. LTFU was defined as the last clinic visit being more than 6 months prior. Multiple Plan-Do-Study-Act (PDSA) cycles were conducted to evaluate quality improvement (QI) interventions that included same-day scheduling of return visits by medical assistants, online scheduling via patient portal, and identification of and focused outreach to the LTFU cohort. The proportion of patients LTFU was analyzed monthly via statistical process control charts (p-charts). Planned data disaggregation by patient demographics and HbA1c levels was used to ensure existing disparities did not worsen.
Results:
We successfully reduced the proportion of patients LTFU from 38% to 15% by 18 months, and improvement was sustained at 27 months. Improvement in the proportion LTFU was seen across different patient demographics (eg, age, sex, race and ethnicity, language for care, health insurance) and HbA1c categories (<7%, 7%-9%, ≥9%) with a reduction in existing disparities.
Conclusions:
Using a PDSA QI framework, simplifying the visit scheduling process and implementing changes in small, iterative cycles led to reduction in the proportion of pediatric patients with T1D who were LTFU.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Kidney Transplant III: Nursing Management
Diabetes Mellitus: Type 2 and Gestational
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Errors occurring during blood pressure monitoring
Several factors...

